End-to-End Services and Solutions to Enable Drug Discovery
WuXi Discovery Services supports clients in the discovery and development of future therapeutics. Through comprehensive discovery and technology platforms, peer-recognized scientific leadership and expertise in oncology, immunology, infectious disease, neurosciences, fibrosis, cardiovascular and metabolic disease, we works collaboratively to rapidly advance drug discovery programs from target through to preclinical selection and beyond.
WuXi Discovery Services encompasses biology, chemistry, structural biology, biophysics and ADME/PK, and is trusted by over 3,000 international clients, ranging from pharma and biotech to academia and non-profit institutions.
Our services include:
- AAV vector design, siRNA, CRISPR/Cas9
- Screening: DEL, HTS, ASMS, fragment-based
- Mouse tumor models: PDX, CDX, syngeneic
- Antivirals: COVID-19 live virus assays, HBV, influenza
- Structure determination: X-ray crystallography, NMR, Cryo-EM
- Chemistry: Oligos, peptides, PROTACs, ADCs, CADD
This integration of capabilities allows a collaborative environment, enabling enhanced efficiency and productivity. WuXi AppTec strives to continually develop and enhance its scientific capabilities and technology to maintain its industry leading position. We aim to provide outstanding services to our existing partners and to the broader drug discovery community!
Over 5,000 chemists, 1,000 biologists and 400 analytical scientists
Laboratories and sites across US, EU and China
Over 7,000 chemical reactions everyday
AAALAC-accredited facility & GCP/CAP compliant laboratories